← Companies|Gyre Ther
Gy

Gyre Ther

Waltham MAFounded 202215 employees
Private CapbiotechPrivateGenetic Medicine
Platform: Epigenome Edit
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
LisotapinarofGYR-8970Approved4RadioligandIL-17AIL-23iCrohn'sMelanoma
GYR-4594GYR-4594Preclinical1Small MoleculePLK4BETiPsoriasisDLBCL
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)
2026-06-12
Lisotapinarof Ph3 Readout
Melanoma
Ph3 Readout
2028-01-16
GYR-4594 Interim
DLBCL
Interim
2028-07-03
Lisotapinarof Ph3 Readout
Melanoma
Ph3 Readout
2028-09-17
Lisotapinarof Ph3 Readout
Melanoma
Ph3 Readout
2030-10-09
Lisotapinarof Ph3 Readout
Ewing Sarcoma
Ph3 Readout